相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers
Xavier Gabaldo Barrios et al.
FAMILIAL CANCER (2017)
Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations
Su Min Ha et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial
Amal Ghouadni et al.
BREAST (2017)
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
Julia Krammer et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Association Between BRCA Status and P53 Status in Breast Cancer: A Meta-Analysis
Lin Peng et al.
MEDICAL SCIENCE MONITOR (2016)
DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
Mohammed Aleskandarany et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers
Jon Zugazagoitia et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry
Jong-Han Yu et al.
JOURNAL OF BREAST CANCER (2014)
Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2
Ashok R. Venkitaraman
SCIENCE (2014)
The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China
Yong Tao Li et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2014)
Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation
Jae Myoung Noh et al.
JOURNAL OF BREAST CANCER (2013)
Triple-negative breast cancer in the older population
P. Boyle
ANNALS OF ONCOLOGY (2012)
Clinical implications for BRCA gene mutation in breast cancer
Jin Xu et al.
MOLECULAR BIOLOGY REPORTS (2012)
Relative contributions of BRCA1 and BRCA2 mutations to triple-negative breast cancer in Ashkenazi Women
E. Comen et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2011)
Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience
Banu Arun et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Triple negative breast cancer - prognostic factors and survival
Tanja Ovcaricek et al.
RADIOLOGY AND ONCOLOGY (2011)
Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis
Eun-Ha Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Triple-Negative Breast Cancer: Unique Biology and Its Management
Rodrigo O. B. Maegawa et al.
CANCER INVESTIGATION (2010)
Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls
Min Wu et al.
MOLECULAR BIOLOGY REPORTS (2010)
Cancer risk reduction in BRCA mutation carriers
Rebecca Kirk
Nature Reviews Clinical Oncology (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer
Deann P. Atchley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers
T. Byrski et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality:: two recurrent mutations were identified
Wen-Feng Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer
Alison M. Hosey et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study
Antonino Musolino et al.
BREAST (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
We of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
K Yoshida et al.
CANCER SCIENCE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma
G Baldassarre et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
分享论文
